291 related articles for article (PubMed ID: 16085013)
1. Treatment strategies and issues in low/intermediate-1-risk myelodysplastic syndrome (MDS) patients.
Bowen DT
Semin Oncol; 2005 Aug; 32(4 Suppl 5):S16-23. PubMed ID: 16085013
[TBL] [Abstract][Full Text] [Related]
2. Managing patients with low-risk MDS.
Sekeres M; Cosgrove D; Falco A
Clin Adv Hematol Oncol; 2006 Jul; 4(7 Suppl 16):1-10; quiz 11-2. PubMed ID: 17139240
[TBL] [Abstract][Full Text] [Related]
3. Advances in supportive care of myelodysplastic syndromes.
Gordon MS
Semin Hematol; 1999 Oct; 36(4 Suppl 6):21-4. PubMed ID: 10530713
[TBL] [Abstract][Full Text] [Related]
4. Strategies for achieving transfusion independence in myelodysplastic syndromes.
Thomas ML
Eur J Oncol Nurs; 2007 Apr; 11(2):151-8. PubMed ID: 16935559
[TBL] [Abstract][Full Text] [Related]
5. [The myelodysplastic syndrome II. New therapeutic principles, course and prognosis].
Hasselbalch HC; Juhl BR; Hansen PB
Ugeskr Laeger; 2002 Jan; 164(4):479-82. PubMed ID: 11838418
[TBL] [Abstract][Full Text] [Related]
6. Alternatives to conventional or myeloablative chemotherapy in myelodysplastic syndrome.
Cazzola M
Int J Hematol; 2000 Aug; 72(2):134-8. PubMed ID: 11039660
[TBL] [Abstract][Full Text] [Related]
7. Supportive care, growth factors, and new therapies in myelodysplastic syndromes.
Hellström-Lindberg E; Malcovati L
Blood Rev; 2008 Mar; 22(2):75-91. PubMed ID: 18068281
[TBL] [Abstract][Full Text] [Related]
8. Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes.
Hellström-Lindberg E; Malcovati L
Semin Hematol; 2008 Jan; 45(1):14-22. PubMed ID: 18179965
[TBL] [Abstract][Full Text] [Related]
9. Refractory anemia and the myelodysplastic syndromes.
Lawrence LW
Clin Lab Sci; 2004; 17(3):178-86. PubMed ID: 15314893
[TBL] [Abstract][Full Text] [Related]
10. [Myelodysplastic syndromes--new treatment options].
Germing U
Med Klin (Munich); 2006 Mar; 101 Suppl 1():123-6. PubMed ID: 16802536
[TBL] [Abstract][Full Text] [Related]
11. Supportive care including growth factors in myelodysplastic syndromes.
Gardin C; Fenaux P
Rev Clin Exp Hematol; 2004 Dec; 8(2):E3. PubMed ID: 16027101
[TBL] [Abstract][Full Text] [Related]
12. Understanding the Myelodysplastic Syndromes.
Kouides PA; Bennett JM
Oncologist; 1997; 2(6):389-401. PubMed ID: 10388074
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
Balleari E; Rossi E; Clavio M; Congiu A; Gobbi M; Grosso M; Secondo V; Spriano M; Timitilli S; Ghio R
Ann Hematol; 2006 Mar; 85(3):174-80. PubMed ID: 16408206
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic growth factors in myelodysplastic syndromes.
Blinder VS; Roboz GJ
Curr Hematol Rep; 2003 Nov; 2(6):453-8. PubMed ID: 14561388
[TBL] [Abstract][Full Text] [Related]
15. Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes.
Jabbour E; Kantarjian HM; Koller C; Taher A
Cancer; 2008 Mar; 112(5):1089-95. PubMed ID: 18186499
[TBL] [Abstract][Full Text] [Related]
16. Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.
Nimer SD
J Clin Oncol; 2006 Jun; 24(16):2576-82. PubMed ID: 16735711
[TBL] [Abstract][Full Text] [Related]
17. Transfusion independence in patients with myelodysplastic syndromes: impact on outcomes and quality of life.
Balducci L
Cancer; 2006 May; 106(10):2087-94. PubMed ID: 16607649
[TBL] [Abstract][Full Text] [Related]
18. Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group.
Götze K; Platzbecker U; Giagounidis A; Haase D; Lübbert M; Aul C; Ganser A; Germing U; Hofmann WK
Ann Hematol; 2010 Sep; 89(9):841-50. PubMed ID: 20567826
[TBL] [Abstract][Full Text] [Related]
19. Update on the therapy for myelodysplastic syndrome.
Kasner MT; Luger SM
Am J Hematol; 2009 Mar; 84(3):177-86. PubMed ID: 19195035
[TBL] [Abstract][Full Text] [Related]
20. Treatment of adult myelodysplastic syndromes.
Hellström-Lindberg E
Int J Hematol; 1999 Oct; 70(3):141-54. PubMed ID: 10561906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
